LANGUAGE
KOREAN
ENGLISH
LOCATION
COMPANY
R&D
R&D Institute
GMP Center
Clinical Development Status
Publications
PRODUCTS
1st Generation
Overview
CARTISTEM
®
PNEUMOSTEM
®
2nd Generation
Overview
SMUP-IA-01
SMUP-IV-01
R&D Inquiries
BUSINESS
CDMO
Quality System
CDMO Service
Quality Control
Global CDMO
CDMO Inquiries
CELLTREE Cord Blood Bank
MOVITA Nutritional Supplements
IR
Stock Information
Disclosure
Financial Information
IR Inquiries
PR
MEDIPOST on Media
Corporate Brochure
CONTACT US
Customer Center
R&D Inquiries
CDMO Inquiries
IR Inquiries
Search Results
MEDIPOST’s phase 1 clinical trial results for its injectable drug for knee osteo…
2021/03/22
MEDIPOST speeds up its global commercialization of CARTISTEM by requesting offic…
2021/03/15
MEDIPOST receives approval for processing the phase 3 clinical trial of CARTISTE…
2021/02/15
MEDIPOST enters an agreement with LG Chem to transfer its MLSC technology, a nex…
2020/12/23
MEDIPOST completes the phase 1 clinical trial of its injectable drug for knee os…
2020/11/16
MEDIPOST Initiates Phase-2 Clinical Trial of CARTISTEM in Japan
2020/09/21
MEDIPOST’s CEO Dr Yang Yoonsun Named on the Forbes 2020 List of Asia’s Power Bus…
2020/09/16
MEDIPOST Completes Phase 2a Clinical Trial of NEUROSTEM for Alzheimer’s Di…
2020/07/07
MEDIPOST’s Clinical Trial of Next-Generation Cell Therapy Product ‘SMUP-IA-01’ M…
2020/05/21
Star Actress Choi Jiwoo Stores Her Baby’s Umbilical Cord Blood Unit at MEDIPOST’…
2020/05/18
Longer-Term Storage of Cord Blood Gains Popularity Over 20,000 Cumulative Cases…
2020/04/29
MEDIPOST Completes Phase 2a Clinical Trial of NEUROSTEM for Alzheimer’s Di…
2020/01/06
Previous
1
2
3
4
5
6
…
14
Next
Menu